Stifel has initiated coverage of Cytokinetics (CYTK) with a buy rating, citing its drug aficamten, valuation and upcoming ...

Stifel Nicolaus analyst Benjamin Burnett maintained a Buy rating on Disc Medicine (IRON – Research Report) today and set a price target of ...

Stifel upgraded IAG (ICAGY) to Buy from Hold with a price target of EUR 5, up from EUR 2.50. The company’s 2025 will be hallmarked by pricing ...

According to Stifel, the Meta partnership positions EssilorLuxottica at the forefront of the smart glasses revolution. The ...

Stifel analysts reiterated their Hold rating on Texas Instruments stock (NASDAQ:TXN) with a steady price target of $200.00.

Stifel analysts maintained a Buy rating for VF Corp (NYSE:VFC) with a steady price target of $27.00. The firm expressed a ...

Shares of Twilio jumped, on pace for the largest percent increase since 2020 after the company slightly raised its revenue expectations for the fourth quarter and said it plans to buy back $2 billion ...

CEO Ron Kruszewski and Yahoo Finance Executive Editor Brian Sozzi at the 2025 World Economic Forum in Davos, Switzerland, to talk about the macro issues impacting the investment banking firm, ...

Stifel analyst Brian Brophy raised the firm’s price target on Quanta Services (PWR) to $388 from $374 and keeps a Buy rating ...

Texas Instruments forecast first-quarter profit below analysts' estimates on Thursday, as the analog chipmaker grapples with ...

With capacity declines driving more freight market gains than demand in 2025, FedEx Freight’s spin-off and march to more ...

Cytokinetics receives a Buy rating from Stifel, with a promising outlook for aficamten in the $3 billion U.S. oHCM market, ...